Abstract

Changes in the level of intracellular calcium ([Ca2+]i) are central to leukocyte signaling and immune response. Although evidence suggests that cigarette smoking affects inflammatory response via an increase in intracellular calcium, it remains unclear if the use of smokeless tobacco (e.g., moist snuff) elicits a similar response. In this study, we evaluated the effects of tobacco product preparations (TPPs), including total particulate matter (TPM) from 3R4F reference cigarettes, smokeless tobacco extract (STE) from 2S3 reference moist snuff, and nicotine alone on Ca2+ mobilization in HL60 cells. Treatment with TPM, but not STE or nicotine alone, significantly increased [Ca2+]i in a concentration-dependent manner in HL60 cells. Moreover, TPM-induced [Ca2+]i increase was not related to extracellular Ca2+ and did not require the activation of the IP3 pathway nor involved the transient receptor potential (TRP) channels. Our findings indicate that, in cells having either intact or depleted endoplasmic reticulum (ER) Ca2+ stores, TPM-mediated [Ca2+]i increase involves cytosolic Ca2+ pools other than thapsigargin-sensitive ER Ca2+ stores. These results, for the first time, demonstrate that TPM triggers [Ca2+]i increases, while significantly higher nicotine equivalent doses of STE or nicotine alone, did not affect [Ca2+]i under the experimental conditions. In summary, our study suggests that in contrast with STE or nicotine preparations, TPM activates Ca2+ signaling pathways in HL60 cells. The differential effect of combustible and non-combustible TPPs on Ca2+ mobilization could be a useful in vitro endpoint for tobacco product evaluation.

Highlights

  • Chronic smoking is associated with the onset of chronic obstructive pulmonary disease and is a major risk factor for lung cancer and cardiovascular disease [1,2,3,4,5]

  • We evaluated intracellular calcium mobilization in HL60 cells following exposure to different concentrations of total particulate matter (TPM), smokeless tobacco extract (STE), and nicotine alone

  • We evaluated the effects of tobacco product preparation (TPP) from combustible and non-combustible tobacco products, as well as of nicotine alone, on cellular Ca2+ mobilization in HL60 cells

Read more

Summary

Introduction

Chronic smoking is associated with the onset of chronic obstructive pulmonary disease and is a major risk factor for lung cancer and cardiovascular disease [1,2,3,4,5]. A number of studies have reported that the use of smokeless tobacco (ST) products is associated with a reduced risk of adverse health effects compared with combustible cigarette smoking [13,14,15,16,17]. For cigarette smokers who are unwilling or unable to quit tobacco product use, reducing exposure to potentially harmful cigarette smoke constituents by switching to alternative tobacco products might lower health risks. This concept is the basis of the tobacco harm reduction principle and relies on the existence of a risk continuum across a range of tobacco products, with combustible cigarettes being considered the most harmful tobacco product [14, 18]. A better understanding of the effects of the tobacco products will aid in developing rapid and functionally relevant tools for tobacco product evaluation

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call